Navigating longevity with industry leaders at MIT AgeLab PLAN Forum
A symposium for financial professionals imagines a new industry around longevity planning.
A symposium for financial professionals imagines a new industry around longevity planning.
Ashutosh Kumar, a materials science and engineering PhD student and MathWorks Fellow, applies his eclectic skills to studying the relationship between bacteria and cancer.
A microneedle patch that delivers immune-regulating molecules can teach T cells not to attack hair follicles, helping hair to regrow.
MIT Department of Mechanical Engineering grad students are undertaking a broad range of innovative research projects.
MIT researchers find circadian variations in liver function play an important role in how drugs are broken down in the body.
A new program is equipping every campus building with an automated external defibrillator.
Graduate student Hammaad Adam is working to increase the supply of organs available for transplants, saving lives and improving health equity.
Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.
Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.
New MIT offering brings a multidisciplinary approach to tackling substance use disorder through biomedical device innovation.
MIT.nano Immersion Lab works with AR/VR startup to create transcontinental medical instruction.
Performing this test could help doctors prevent dysfunction that can occur when the right and left ventricles of the heart become imbalanced.
A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.
Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.
Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.